Clinerion teams with Medsoft to extend reach in country of Georgia

Clinerion is partnering with electronic health records software company Medsoft to expand its reach in the country of Georgia. (Intrepid Travel)

Clinerion, a Swiss trial recruitment specialist, is partnering with electronic health records software company Medsoft to expand its reach in the country of Georgia.

Medsoft, which is based in Tbilisi, Georgia, has a decade’s worth of experience in eHealth and supports hospitals and other healthcare institutions in the country with technology. The company boasts more than 40 hospitals and medical centers in the country that use its software.

The company’s Medwork hospital information system (HIS) is integrated with the Georgian Ministry of Health, financial systems, and laboratory information systems that provide smoother and more effective information management, according to a release.

Training Course

BioBasics: Biotech For The Non-Scientist

BioBasics: Biotech for the Non-Scientist is a two-day course for those who want to better understand the science driving the industry. The course starts with basic scientific concepts and quickly delves into the causes of genetic and infectious disease and the therapeutic strategies used to mitigate disease. The latest innovations in immunotherapies, gene therapy, checkpoint inhibitors, CAR-T and more are explained.

Under the partnership, Medsoft will support Clinerion in integrating hospitals in the country into Clinerion’s international network of partner hospitals using its Patient Network Explorer platform. Financial terms of the agreement weren’t disclosed.

“As a HIS provider with a strong presence in Georgia, we consider Medsoft an important partner in our expansion in the region, enabling Clinerion to reach more patients,” Ian Rentsch, Clinerion’s chief executive, said in a statement.

Just last week, Clinerion announced a partnership with Citeline as part of an effort to give clinical researchers a more comprehensive approach to making evidence-based decisions.

Suggested Articles

Gottlieb challenged industry and academia to invest in new approaches and realign incentives to make clinical research more agile and effective.

Chinese biotech HitGen has inked a collaboration deal with India’s Sun Pharma Advanced Research arm to identify novel small molecule leads.

Charles River Labs has inked a licensing deal with drug discovery and development services provider Crown Bioscience for expanded access to the ZDSD rat model.